MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-19-0006284
Oriental Pharmaceutical Industries Limited
Oriental Pharmaceutical Industries Limited - financial services in Vishalgad, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹1.75 Cr
▼ 3.59% YoY
Net loss · FY 2024
₹75.34 Lakh
Net margin -43.2%
EBITDA · FY 2024
₹1.37 Cr
EBITDA margin 78.7%
Authorised capital
₹60 Lakh
Registered with MCA
Paid-up capital
₹6.42 Lakh
Issued & subscribed
Open charges
₹50.27 Cr
Satisfied ₹25 Cr
Company age
85 yrs
Est. 1941
Directors on board
3
As per MCA filings
About Oriental Pharmaceutical Industries Limited
Data last updated:
Oriental Pharmaceutical Industries Limited is a public limited company based in Vishalgad, Maharashtra, India. It operates in the brokerage and trading services segment of the financial services sector. It was incorporated on 11 March 1941 and has been in existence for over 85 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1941PLC003286. Its GSTIN is 27AAACO0946J1ZE (Maharashtra).
The company has an authorised share capital of ₹60 Lakh and a paid-up capital of ₹6.42 Lakh. It was formerly known as The Oriental Pharmaceutical Industries Limited. It is led by directors including Youhaan Amol Kapadia and Amol Jagdish Kapadia.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Factory Premisesoff Polson Ltd Ambaghat, Vishalgad, Maharashtra, India – 415101.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.75 Cr. For the same year it recorded a net loss of ₹75.34 Lakh (net margin -43.2%) and EBITDA of ₹1.37 Cr (EBITDA margin 78.7%). Revenue has declined at a compounded annual rate (CAGR) of 5% over three years.
Its group structure includes 2 subsidiaries.
As per MCA filings, the company has open charges of ₹50.27 Cr and satisfied charges of ₹25 Cr on record. Court records list 3 cases involving the company, including 2 filed by the company and 1 filed against it.
Oriental Pharmaceutical Industries Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0006284). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24239MH1941PLC003286
Registration Number 003286
Incorporation Date 11 March 1941
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-19-0006284
CIN history
Oriental Pharmaceutical Industries has one previous CIN (Corporate Identification Number): L24239MH1941PLC003286. The current CIN is U24239MH1941PLC003286, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239MH1941PLC003286 | Current |
| L24239MH1941PLC003286 | Previous |
Key People
Youhaan Amol Kapadia Director Amol Jagdish Kapadia Director Dhau Gangaram Lambore Director Recognitions & Rankings of Oriental Pharmaceutical Industries
Contact details
Oriental Pharmaceutical Industries Limited's registered office is in Vishalgad, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFactory Premisesoff Polson Ltd Ambaghat, Vishalgad, Maharashtra, India – 415101
- IndustryFinancial Services, Brokerage & Trading Services
To see the full contact details of Oriental Pharmaceutical Industries Limited, buy the company report.
Comprehensive company report
Oriental Pharmaceutical Industries Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Oriental Pharmaceutical Industries Limited
FY 2024 filings availableOriental Pharmaceutical Industries Limited reported revenue of ₹1.75 Cr for FY 2024.
Revenue · FY 2024
₹1.75 Cr
Net loss · FY 2024
₹75.34 Lakh margin -43.2%
EBITDA · FY 2024
₹1.37 Cr margin 78.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
3 years · compounded
▼ 5%
EBITDA CAGR growth
1 year
▲ 12%
3 years · compounded
▼ 9%
5 years · compounded
▲ 90%
Revenue has declined at a compounded annual rate (CAGR) of 5% over three years. EBITDA rose 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.37 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹75.34 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 78.7% | ||||
| Net Profit Margin | -43.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Oriental Pharmaceutical Industries Limited, buy the company report.
Board of directors of Oriental Pharmaceutical Industries Limited
Oriental Pharmaceutical Industries has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Youhaan Amol Kapadia | Director | 19 Dec 2023 | 2 Years 10 Months | Current |
| Amol Jagdish Kapadia Also directs: Coriander Homes Limited Liability Partnership, Coriander Plaza LLP, Brookstone Properties LLP and 5 more | Director | 01 Sep 1995 | 31 Years 1 Months | Current |
| Dhau Gangaram Lambore Also directs: Polson Ltd, Polson Butter Private Limited, New Commercial Investment and Trading Co Ltd and 1 more | Director | 13 Feb 2014 | 12 Years 8 Months | Current |
Peer comparison
Oriental Pharmaceutical Industries Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| The Varma Pharmacy Private Limited | ₹1.75 Cr (FY 2025) | 10.0% | Pune, Maharashtra, India | |||
| Universal Drug House Pvt Ltd | ₹1.75 Cr (FY 2025) | -3.0% | Beleghata, West Bengal, India | |||
| Ultracare Remedies Private Limited | ₹1.75 Cr (FY 2025) | -16.0% | Rajkot, Gujarat, India | |||
| Oriental Pharmaceutical Industries Limitedthis company | ₹1.75 Cr (FY 2024) | -₹75.34 Lakh | -43.2% | Vishalgad, Maharashtra, India | ||
| Satellite Pharmaceuticals Private Limited | ₹1.74 Cr (FY 2025) | 18.0% | Mumbai, Maharashtra, India | |||
| Divine Formulations Private Limited | ₹1.74 Cr (FY 2025) | Mumbai, Maharashtra, India | ||||
| Adam Laboratories Private Limited | ₹1.74 Cr (FY 2024) | 17.0% | Uttar Pradesh, India |
To see the full peer comparison of Oriental Pharmaceutical Industries Limited, buy the company report.
Auditor
Oriental Pharmaceutical Industries Limited is audited by R G B & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R G B & ASSOCIATES | FY 2023 | 144967W |
Shareholding
The shareholding of Oriental Pharmaceutical Industries Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Oriental Pharmaceutical Industries Limited, buy the company report.
Charges & borrowings
Open charges
₹50.27 Cr
Satisfied charges
₹25 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Dec 2017 | 100159148 | Hdfc Bank Limited | ₹23 Cr | Open | |
| 10 Nov 2017 | 100151793 | Hdfc Bank Limited | ₹27.27 Cr | Open | |
| 31 Mar 2015 | 10558556 | Kotak Mahindra Bank Limited | ₹25 Cr | Satisfied |
To see the full charge records of Oriental Pharmaceutical Industries Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Oriental Pharmaceutical Industries Limited has 3 court cases on record: 2 filed by Oriental Pharmaceutical Industries, 1 filed against it. All cases are disposed.
Total cases
3
Filed by the company
2
Filed against the company
1
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 0 | 0 |
| District courts | 1 | 1 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (CSD) | Filed by the company | Disposed |
| Bombay High Court | Court case (CSP) | Filed by the company | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Civil suit | Filed against the company by an individual | Disposed |
To see the full case history of Oriental Pharmaceutical Industries Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Oriental Pharmaceutical Industries Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Oriental Pharmaceutical Industries has 2 subsidiary companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
2
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Coriander Industries Private Limited | U70101MH1992PTC067940 | |
| The New Commercial Mills Company Limited | U99999MH1952PLC214186 |
To see the full group structure of Oriental Pharmaceutical Industries Limited, buy the company report.
GST
Oriental Pharmaceutical Industries has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACO0946J1ZE | Maharashtra | Active | 18 Jul 2020 |
To see the full GST registrations and return filing status of Oriental Pharmaceutical Industries Limited, buy the company report.
Recent activity
Oriental Pharmaceutical Industries Limited has 8 board changes on record since 1995: 3 appointments and 5 cessations. The latest: Youhaan Amol Kapadia ceased to be Additional Director on 29 Sep 2024.
AGM
Oriental Pharmaceutical Industries Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Youhaan Amol Kapadia ceased to be Additional Director.
Filing
Oriental Pharmaceutical Industries Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai I.
Ceased
Sushila Jagdish Kapadia ceased to be Director.
Appointed
Youhaan Amol Kapadia was appointed as Director.
Charges
A charge with Hdfc Bank Limited of Rs. 2,727.00 Lakh registered on 10 Nov 2017 with Charge ID 100151793 was modified on 21 Apr 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 2,300.00 Lakh with Charge ID 100159148 was registered on 29 Dec 2017.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 2,727.00 Lakh with Charge ID 100151793 was registered on 10 Nov 2017.
Charges
A charge registered on 31 Mar 2015 via Charge ID 10558556 with Kotak Mahindra Bank Limited was fully satisfied on 09 Oct 2017.
Charges
A charge with Kotak Mahindra Bank Limited amounted to Rs. 2,500.00 Lakh with Charge ID 10558556 was registered on 31 Mar 2015.
Ceased
Dhau Gangaram Lambore ceased to be Additional Director.
Appointed
Dhau Gangaram Lambore was appointed as Director.
4 earlier events are in the company report.
Frequently asked questions
Oriental Pharmaceutical Industries is an active public limited company based in Vishalgad, Maharashtra, India. The company works in brokerage and trading services, within the financial services industry. It was incorporated on 11 March 1941 (85+ years old) and is registered under CIN U24239MH1941PLC003286.
Oriental Pharmaceutical Industries has 3 current directors:
- Youhaan Amol Kapadia - Director
- Amol Jagdish Kapadia - Director
- Dhau Gangaram Lambore - Director
The latest financial statements of Oriental Pharmaceutical Industries on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Oriental Pharmaceutical Industries is 27AAACO0946J1ZE, registered in Maharashtra.
The CIN (Corporate Identification Number) of Oriental Pharmaceutical Industries is U24239MH1941PLC003286. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Oriental Pharmaceutical Industries has 3 court cases on record: 2 filed by the company and 1 filed against it. Most are in the high courts.
Oriental Pharmaceutical Industries was incorporated on 11 March 1941, making it 85+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Oriental Pharmaceutical Industries by revenue are The Varma Pharmacy Private Limited, Universal Drug House Pvt Ltd, Ultracare Remedies Private Limited, Satellite Pharmaceuticals Private Limited, Divine Formulations Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Youhaan Amol Kapadia ceased to be Additional Director on 29 Sep 2024. Sushila Jagdish Kapadia ceased to be Director on 19 Dec 2023. Youhaan Amol Kapadia was appointed as Director on 19 Dec 2023. Oriental Pharmaceutical Industries has 8 board changes on record in total.
Yes, Oriental Pharmaceutical Industries is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0006284).
The registered office of Oriental Pharmaceutical Industries is at Factory Premisesoff Polson Ltd Ambaghat, Vishalgad, Maharashtra, India – 415101.